Skip to main content
Home
Latest news
Browse topics
Lupus Rheumatoid arthritis Spondyloarthropathies COVID-19 Browse all topics
In focus
Bimekizumab: Dual IL-17A/IL-17F inhibition in SpA Anifrolumab for the treatment of SLE JAK inhibitor safety: Weighing up the data and understanding the risks Rituximab and rheumatology practice in the COVID-19 era Safety snapshot: Upadacitinib in patients with PsA Repurposing rheumatology drugs for COVID-19 Telemedicine in rheumatology: COVID-19 and beyond Managing PsA in resource-limited settings
Conferences
ACR Convergence 2022 EULAR 2022 Congress
About us
Medicine Matters Rheumatology
EXTENDED SEARCH

Quality of life

Quality of life

Rituximab and rheumatology practice in the COVID-19 era

How can rheumatologists respond to the challenges associated with rituximab use during the pandemic?

Browse the hub

Anifrolumab for the treatment of lupus

Perspective on the approval of anifrolumab and the importance of endpoints in lupus trials.

Visit the hub

New additions to the Adis Journal Club

A monthly selection of topical peer-reviewed articles from the Adis journals, curated by the editors.

Visit the hub

JAK inhibitor safety

Data summary, expert discussion, & research news on the potential risks associated with JAK inhibitors.

ACR Convergence 2021 highlights

3–9 November: Keep up with the latest news and interviews from the conference.

Visit the conference hub

Febuxostat and cardiovascular risk in people with gout

How will the FAST trial results impact regulatory guidance & clinical practice?

Read the article

Telemedicine in rheumatology

Experts discuss the increasing use of telemedicine in rheumatology during the COVID-19 pandemic.

Browse the hub

Get ready for ACR Convergence 2020

5 – 9 November: Preview the conference with session recommendations and updates on upcoming coverage.

Visit the conference hub

27-09-2018 | Fibromyalgia | Editorial | Article

Treatment and outcomes of pediatric fibromyalgia: More than resolving pain

David Sherry discusses various pharmacologic and non-pharmacologic treatments for management of pediatric fibromyalgia, and outlines the impact of an interdisciplinary approach on physical function, mental health and pain outcomes in these patients.

Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: Review of the general methodology

The aim of this project was to cross-culturally adapt and validate the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) questionnaire in 54 languages across 52 different countries that are members of the Paediatric Rheumatology International Trials Organisation (PRINTO) [read more].
Bovis F et al. Rheumatol Int 2018; 38(Suppl 1): 5–17. doi: 10.1007/s00296-018-3944-1

Cross-cultural adaptation and psychometric evaluation of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR) in 54 languages across 52 countries: Review of the general methodology

07-09-2018 | Systemic lupus erythematosus | Article

Long‐term clinical outcomes in a cohort of adults with childhood‐onset systemic lupus erythematosus

Groot N et al. Arthritis Rheumatol 2018. doi: 10.1002/art.40697

A multidisciplinary approach to managing chronic pain in children

Editorial board member Sangeeta Sule discusses the challenges faced when managing chronic pain in children and adolescents [read more].

A multidisciplinary approach to managing chronic pain in children

31-07-2018 | Pain disorders | View from the clinic | Article

A multidisciplinary approach to managing chronic pain in children

Editorial board member Sangeeta Sule discusses the challenges faced when managing chronic pain in children and adolescents.

13-07-2018 | Juvenile idiopathic arthritis | Article

Orofacial symptoms and oral health-related quality of life in juvenile idiopathic arthritis: A two-year prospective observational study

Rahimi H et al. Pediatr Rheumatol 2018; 16: 47. doi: 10.1186/s12969-018-0259-4

10-07-2018 | Pediatric | Article

Adverse childhood experience and rheumatic diseases

Luiz APL et al. Clin Rheumatol 2018. doi: 10.1007/s10067-018-4200-5

28-06-2018 | Juvenile idiopathic arthritis | Article

Association of hand grip strength with disease activity, disability, and quality of life in children and adolescents with juvenile idiopathic arthritis

Rashed AM et al. Adv Rheumatol 2018; 58: 11. doi: 10.1186/s42358-018-0012-1

25-06-2018 | Dermatomyositis | Article

Development of practice and consensus-based strategies including a treat-to-target approach for the management of moderate and severe juvenile dermatomyositis in Germany and Austria

Hinze CH et al. Pediatr Rheumatol 2018; 16: 40. doi: 10.1186/s12969-018-0257-6

08-06-2018 | Pain | Review | Article

Cannabinoids for the treatment of rheumatic diseases: Where do we stand?

Katz-Talmor D et al. Nat Rev Rheumatol 2018. doi: 10.1038/s41584-018-0025-5

05-06-2018 | Juvenile idiopathic arthritis | Article

A new biopsychosocial and clinical questionnaire to assess juvenile idiopathic arthritis: JAB-Q

Unal E et al. Rheumatol Int 2018. doi: 10.1007/s00296-018-4075-4

Next
Image Credits